On this page:Overview Publications Researchers Institutions Open access

ScholarIQanswers from OpenAlex

Royal Marsden NHS Foundation Trust

InstitutionResearch output, impact & collaborations

Royal Marsden NHS Foundation Trust is a institution indexed in ScholarIQ from OpenAlex.

What is known about Royal Marsden NHS Foundation Trust?

ScholarIQrecord summary

Royal Marsden NHS Foundation Trust is a research organisation in London, GB. OpenAlex records 17,874 works and 2,603,546 citations for it. 3,117 researchers list it as their most recent affiliation.

How many works does Royal Marsden NHS Foundation Trust have?

ScholarIQindexed works

Royal Marsden NHS Foundation Trust has 17,874 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for Royal Marsden NHS Foundation Trust →

How many citations does Royal Marsden NHS Foundation Trust have?

ScholarIQcitation count

Royal Marsden NHS Foundation Trust has 2,603,546 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for Royal Marsden NHS Foundation Trust →

How many researchers are at Royal Marsden NHS Foundation Trust?

ScholarIQresearcher count

Royal Marsden NHS Foundation Trust has 3,117 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at Royal Marsden NHS Foundation Trust?

ScholarIQavg h-index

Royal Marsden NHS Foundation Trust has an average h-index of 71.2 in OpenAlex.

Open the OpenAlex record →

What is the ROR of Royal Marsden NHS Foundation Trust?

ScholarIQror

The ROR for Royal Marsden NHS Foundation Trust is on the source record.

Open the ROR →

What is the OpenAlex record for Royal Marsden NHS Foundation Trust?

ScholarIQopenalex

The OpenAlex for Royal Marsden NHS Foundation Trust is on the source record.

Open the OpenAlex →

What is the Wikidata of Royal Marsden NHS Foundation Trust?

ScholarIQwikidata

The Wikidata for Royal Marsden NHS Foundation Trust is on the source record.

Open the Wikidata →

Who are the most-cited researchers behind Royal Marsden NHS Foundation Trust?

ScholarIQtop researchers by citations

Johann S. de Bono · Prostate Cancer Treatment and Research

2,470 works138,085 citations

David Cunningham · Colorectal Cancer Treatments and Studies

2,042 works132,293 citations

Mitch Dowsett · Estrogen and related hormone effects

1,593 works112,249 citations

Rosalind A. Eeles · BRCA gene mutations in cancer

1,110 works89,511 citations

Kevin J. Harrington · Head and Neck Cancer Studies

1,471 works74,834 citations

What are the most-cited papers on Royal Marsden NHS Foundation Trust?

ScholarIQmost cited works

Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

Martin Reck, Delvys Rodríguez‐Abreu, Andrew Robinson, Rina Hui, Tibor Csőszi, Andrea Fülöp, Maya Gottfried, Nir Peled, Ali Tafreshi, Sinéad Cuffe, Mary O’Brien, Suman Rao, Katsuyuki Hotta, Melanie A. Leiby, Gregory M. Lubiniecki, Yue Shentu, Reshma Rangwala, Julie R. Brahmer

New England Journal of Medicine. 201610,184 CitationsOPEN ACCESS

Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer

Ian F. Tannock, Ronald de Wit, William R. Berry, J Horti, A Płużańska, Kim N., Stéphane Oudard, Christine Théodore, Nicholas D. James, Ingela Turesson, Mark Rosenthal, Mario A. Eisenberger

New England Journal of Medicine. 20045,744 Citations

Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

Robert L. Ferris, George R. Blumenschein, Jérôme Fayette, J. Guigay, A. Dimitrios Colevas, Lisa Licitra, Kevin J. Harrington, Stefan Kasper, Everett E. Vokes, Caroline Even, Francis P. Worden, Nabil F. Saba, Lara Carmen Iglesias Docampo, Robert I. Haddad, Tamara Rordorf, Naomi Kiyota, Makoto Tahara, Manish Monga, Mark Lynch, William J. Geese, Justin Kopit, James W. Shaw, Maura L. Gillison

New England Journal of Medicine. 20165,125 CitationsOPEN ACCESS

Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer

Martine Piccart, Marion Procter, Brian Leyland‐Jones, Aron Goldhirsch, Michael Untch, Ian Smith, Luca Gianni, José Baselga, Richard H. Bell, Christian Jackisch, David Cameron, Mitch Dowsett, Carlos H. Barrios, Günther Steger, Chiun‐Sheng Huang, Michael Andersson, Moshe Inbar, Mikhail Lichinitser, István Láng, Ulrike Nitz, Hiroji Iwata, Christoph Thomssen, Caroline Lohrisch, Thomas Suter, Josef Rüschoff, Tamás Sütö, Victoria Greatorex, Carol Ward, Carolyn Straehle, Eleanor McFadden, Mirko Dolci, Richard D. Gelber

New England Journal of Medicine. 20055,111 CitationsOPEN ACCESS

Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy

Howard I. Scher, Karim Fizazi, Fred Saad, Mary‐Ellen Taplin, Cora N. Sternberg, Kurt Miller, Ronald de Wit, Peter F.A. Mulders, Kim N., Neal D. Shore, Andrew J. Armstrong, Thomas W. Flaig, Aude Fléchon, Paul N. Mainwaring, Mark T. Fleming, John D. Hainsworth, Mohammad Hirmand, Bryan Selby, Lynn Seely, Johann S. de Bono

New England Journal of Medicine. 20124,604 CitationsOPEN ACCESS

Who collaborates most closely around Royal Marsden NHS Foundation Trust?

ScholarIQco-authorship network

United States

100%

MOST FREQUENT PARTNER INSTITUTIONS

Merck & Co., Inc., Rahway, NJ, USA (United States)

How much of the research on Royal Marsden NHS Foundation Trust is open access?

ScholarIQopen access share

83%OPEN ACCESS

Gold

Green

Hybrid

Bronze

67%

Closed

17%